Letters and drug alerts sent to healthcare professionals in September 2019

2019-10-18T15:39:23+01:00

Letters were issued about parenteral nutrition products, ranibizumab, ingenol mebutate gel, adrenaline auto-injectors, and fingolimod. Recall alerts were recently issued about ranitidine, aripiprazole, and bisacodyl.